Acute lymphoblastic leukaemia trials in Czechia
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Brno, Plzen 23, Poruba, Prague
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Brno-Sever, Prague
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 3Taking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Brno, Olomouc, Plzen 23, Prague
- Age
- 1 year to 64 years
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - Phase 2/3Taking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Prague
- Age
- 3 months to 25 years
- People
- 1,000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Brno-Sever, Olomouc, Prague 5
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 3Taking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Hradec Králové, Ostrova, Prague
- Age
- 18 years and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - Phase 1/2Not yet taking people in CzechiaStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Prague
- Age
- Up to 64 years
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 · EU 2025-522019-40-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Brno-Sever, Prague
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Prague
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 2Not yet taking people in CzechiaA PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
- Where
- Brno, Prague
- People
- 86 worldwide
- Run by
- Centre Hospitalier De Versailles
See details and how to join2024-516570-30-00 · EU 2024-516570-30-00 - Phase 1/2Taking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Prague 5
- Age
- Up to 17 years
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Brno, Olomouc, Prague
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - Phase 3Taking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Brno, Hradec Králové, Ostrava, Prague
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - Phase 2Taking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Brno, Prague
- Age
- Up to 17 years
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - Phase 3Taking peopleTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
- Where
- Brno-Sever, České Budějovice, Novy Hradec Kralove, Olomouc, Ostrava, Plzen 23, Prague, Usti Nad Labem
- Age
- Up to 17 years
- People
- 5,000 worldwide
- Run by
- Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00 - Phase 1Taking peopleCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
- Where
- Prague
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257 · EU 2024-510815-30-00